Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates

Emerging Infectious Diseases

Volumn 7, Issue 1, 2001, Pages 24-34

  Engberg, Jørgen ^a   Aarestrup, Frank M ^b   Taylor, Diane E ^c   Gerner Smidt, Peter ^a   Nachamkin, Irving ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; CHLORAMPHENICOL; ERYTHROMYCIN; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; QUINOLONE DERIVATIVE; SPIRAMYCIN; TYLOSIN;

BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; DISEASE PREDISPOSITION; DRUG CHOICE; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; REVIEW;

EID: 0035108778     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0701.010104     Document Type: Review

References (95)

1. Campylobacter jejuni and the expanding spectrum of related infections
2. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin
3. Fluoroquinolones and bacterial enteritis, when and for whom?
4. Quinolone resistance and Campylobacter spp.
5. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin
6. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine
7. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998
8. Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli
9. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations
10. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations
11. Increased resistance to quinolones in Campylobacter jejuni: A genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates
12. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC
13. Characterization of high-level quinolone resistance in Campylobacter jejuni
14. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni
15. Overview of quinolone usage for food-producing animals
16. Antibiotic resistance in the European union associated with therapeutic use in veterinary medicines
17. The induction of quinolone resistance in Campylobacter in broilers by quinolone treatment
18. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark
19. Prevalence, biotypes, plasmid profile and antimicrobial resistance of Campylobacter isolates from wild and domestic animals from Northeast Portugal
20. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998
21. Erythromycin-resistant thermophilic Campylobacter species isolated from pigs
22. Serotypes and typability of Campylobacter jejuni and Campylobacter coli isolated from poultry products
23. Fluoroquinolone resistance in Campylobacter spp. isolated from human stools and poultry products
24. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan
25. Ciprofloxacin resistant Campylobacter spp. in humans: An epidemiological and laboratory study
26. Water-borne Campylobacter jejuni infection in a Danish town - A 6-week continuous source outbreak
27. Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: Evidence of identical clones infecting humans, poultry, and cattle
28. Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine
29. Campylobacter jejuni as a cause of traveler's diarrhea: Clinical features and antimicrobial susceptibility
30. Short-term treatment of traveler's diarrhea with norfloxacin: A double-blind, placebo-controlled study during two seasons
31. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland
32. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: A 10-year follow-up report
33. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients
34. Comparison of two agar dilution methods and three agar diffusion methods including the E-test for antibiotic susceptibility testing of thermophilic Campylobacter species
35. Direct milk excretion of Campylobacter jejuni in a dairy cow causing cases of human enteritis
36. Continuous source outbreak of campylobacteriosis traced to chicken
37. Restriction fragment length polymorphism analysis of the flaA gene of Campylobacter jejuni for subtyping human, animal and poultry isolates
38. Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea
39. High-level quinolone resistance in clinical isolates of Campylobacter jejuni
40. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: Comparison of clinical features and review
41. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community
42. Campylobacter infections in HIV-infected patients: Clinical and bacteriological features
43. Isolation of Campylobacter jejuni strains resistant to nalidixic acid and fluoroquinolones from children with diarrhea in Athens, Greece
44. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients
45. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides
46. Further increase in ciprofloxacin-resistant Campylobacter jejuni/coli in Styria, Austria
47. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada
48. Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis
49. Les infections à Campylobacter en France (1986-1997)
50. Biochemical characteristics, serogroup distribution, antibiotic susceptibility and age-related significance of Campylobacter strains causing diarrhoea in humans in Hungary
51. Emergence of quinolone-resistance in clinical isolates of Campylobacter jejuni in Japan
52. Clinical microbiology of Campylobacter enteritis in our experience
53. Antimicrobial susceptibility of Campylobacter and Yersinia enterocolitica isolates
54. A one-year study of enteric Campylobacter infections in Singapore
55. Campylobacter spp. antibiotic susceptibility
56. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years
57. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994
58. Drug resistance in C. jejuni, C. coli and C. lari isolated from humans in Wales and North West England during 1997
59. The E-Test and Campylobacter jejuni
60. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli to ciprofloxacin, erythromycin and tetracycline from 1982 to 1992
61. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin
62. Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria
63. Examples of in-vitro quinolone resistance prevalence trends in humans and animal isolates of food-borne Salmonella and Campylobacter
64. Antibiotics in veterinary medicine and public health
65. Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp.
66. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent
67. Emerging quinolone resistance in campylobacters
68. Resistance to ciprofloxacin in Campylobacter spp.
69. Quinolone resistance and Campylobacter species
70. Increasing rates of ciprofloxacin resistant Campylobacter
71. Medical and veterinary use of antimicrobial agents: Implications for public health. A clinician's view on antimicrobial resistance
72. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991
73. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus
74. Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales - The current situation
75. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT 104
76. The need for a veterinary antibiotic policy
77. Use of quinolones in food animals and potential impact on human health